PRKRA antibody
Quick Overview for PRKRA antibody (ABIN7468801)
Target
See all PRKRA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Frog, Human
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the center region of human PACT. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: Jurkat
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.51 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- PRKRA (Protein Kinase, Interferon-Inducible Double Stranded RNA Dependent Activator (PRKRA))
-
Alternative Name
- protein activator of interferon induced protein kinase EIF2AK2
-
Background
-
Synonyms: protein activator of interferon induced protein kinase EIF2AK2 , DYT16 , HSD14 , PACT , RAX
Background: This gene encodes a protein kinase activated by double-stranded RNA which mediates the effects of interferon in response to viral infection. Mutations in this gene have been associated with dystonia. Alternative splicing results in multiple transcript variants. [provided by RefSeq]
-
Molecular Weight
- 34 kDa
-
Gene ID
- 8575
-
UniProt
- O75569
-
Pathways
- Regulatory RNA Pathways
Target
-